C5a controls TLR-induced IL-10 and IL-12 production independent of phosphoinositide 3-kinase. 2011

Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan.

The complement system is a classic central player in innate immunity. Most pathogens activate both complement and the toll-like receptor (TLR) pathway. Therefore, to provide a more comprehensive understanding of innate immunity, it is important to understand the crosstalk between these two systems. Mouse macrophages produce IL-12 and IL-10 in response to TLR ligands such as LPS, CpG, Poly I:C and Malp2. The TLR-induced IL-12 production was decreased, while that of IL-10 was increased by concurrent stimulation with a complement fragment C5a. Pharmacological studies have suggested that C5a regulates TLR4-induced IL-12 production in a phosphoinositide 3-kinase (PI3K)-dependent mechanism. In the present study, however, we found that the C5a-mediated changes can be observed in macrophages from mice lacking PI3K p85α or PI3K p110γ. The result indicates that the C5a action is PI3K-independent; neither class IA nor class IB PI3K subtype is involved in this regulation. The actions of C5a were sensitive to pertussis toxin and PD98059, suggesting a role of G protein-mediated activation of the Erk1/2 pathway.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D000077191 Wortmannin An androstadiene metabolite produced by the fungi PENICILLIUM funiculosum that inhibits PHOSPHATIDYLINOSITOL-3-KINASES and alloantigen-specific activation of T-LYMPHOCYTES in human tumor cell lines. It is widely used in CELL BIOLOGY research and has broad therapeutic potential. MS 54,MS-54,MS54
D000081082 Phosphoinositide-3 Kinase Inhibitors Agents that inhibit PHOSPHOINOSITIDE-3 KINASE activity. Phosphoinositide-3 Kinase Inhibitor,Inhibitor, Phosphoinositide-3 Kinase,Inhibitors, Phosphoinositide-3 Kinase,Kinase Inhibitor, Phosphoinositide-3,Kinase Inhibitors, Phosphoinositide-3,Phosphoinositide 3 Kinase Inhibitor,Phosphoinositide 3 Kinase Inhibitors
D000730 Androstadienes Derivatives of the steroid androstane having two double bonds at any site in any of the rings.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
November 2006, Journal of immunology (Baltimore, Md. : 1950),
Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
August 2018, Cytokine,
Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
July 2007, Journal of immunology (Baltimore, Md. : 1950),
Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
March 2012, Scandinavian journal of immunology,
Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
December 2012, Journal of biochemistry,
Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
February 2007, Molecular immunology,
Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
August 2020, Bioscience reports,
Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
January 2011, PloS one,
Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
October 2005, Journal of immunology (Baltimore, Md. : 1950),
Natsumi Okazaki, and Kaoru Hazeki, and Tatsuhiro Izumi, and Kiyomi Nigorikawa, and Osamu Hazeki
June 2006, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!